These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets. Baarsma HA; Königshoff M; Gosens R Pharmacol Ther; 2013 Apr; 138(1):66-83. PubMed ID: 23328704 [TBL] [Abstract][Full Text] [Related]
28. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802 [TBL] [Abstract][Full Text] [Related]
29. The ups and downs of Wnt signaling in prevalent neurological disorders. De Ferrari GV; Moon RT Oncogene; 2006 Dec; 25(57):7545-53. PubMed ID: 17143299 [TBL] [Abstract][Full Text] [Related]
30. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Lin MT; Beal MF Nature; 2006 Oct; 443(7113):787-95. PubMed ID: 17051205 [TBL] [Abstract][Full Text] [Related]
31. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway. Liu N; Shi S; Deng M; Tang L; Zhang G; Liu N; Ding B; Liu W; Liu Y; Shi H; Liu L; Jin Y J Bone Miner Res; 2011 Sep; 26(9):2082-95. PubMed ID: 21638320 [TBL] [Abstract][Full Text] [Related]
32. BRI2 as a central protein involved in neurodegeneration. Tsachaki M; Ghiso J; Efthimiopoulos S Biotechnol J; 2008 Dec; 3(12):1548-54. PubMed ID: 19072909 [TBL] [Abstract][Full Text] [Related]
33. Neurodegenerative conditions associated with ageing: a molecular interplay? Troulinaki K; Tavernarakis N Mech Ageing Dev; 2005 Jan; 126(1):23-33. PubMed ID: 15610759 [TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of neurodegeneration. Dormann D Semin Cell Dev Biol; 2020 Mar; 99():131-132. PubMed ID: 31902626 [No Abstract] [Full Text] [Related]
35. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Ross CA; Pickart CM Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047 [TBL] [Abstract][Full Text] [Related]
36. The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Berwick DC; Harvey K Biochem Soc Trans; 2012 Oct; 40(5):1123-8. PubMed ID: 22988876 [TBL] [Abstract][Full Text] [Related]
37. International Meeting Molecular Neurodegeneration: News and Views in Molecular Neuroscience in Health and Disease. Delmenhorst, Germany, July 20-22, 2015. Gozes I; Baas PW; Richter-Landsberg C J Mol Neurosci; 2015 Oct; 57(2):153-9. PubMed ID: 26319265 [No Abstract] [Full Text] [Related]
38. Abstracts of the 2011 International Conference on Molecular Neurodegeneration. Shanghai, China. September 22-24, 2011. Murad F Mol Neurodegener; 2012 Feb; 7 Suppl 1(Suppl 1):L1-26, O1-14, S1-35. PubMed ID: 22734668 [No Abstract] [Full Text] [Related]
39. Molecular Basis for Signal Transduction in Neurodegeneration and Neuroregeneration. Abstracts of the 20th Biennal Meeting of the ISN Satellite Symposium, August 27-30, 2005, Warszawa, Poland. Pharmacol Rep; 2005; 57(3):405-44. PubMed ID: 15985725 [No Abstract] [Full Text] [Related]
40. Abstracts of the Molecular Neurodegeneration: Basic biology and disease pathways meeting, 10-12 September 2013, Cannes, France. Tanzi RE Mol Neurodegener; 2013 Sep; 8 Suppl 1(Suppl 1):O1-P70. PubMed ID: 24625280 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]